NCT00894530

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 314 (actual)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% versus placebo over a four-week treatment period.

Conditions

• Blepharitis

Interventions

Type	Name	Description
DRUG	Azithromycin ophthalmic solution, 1%	One drop in each eye twice a day for the first two days; then one drop in each eye once a day for 26 days
DRUG	Placebo	One drop in each eye twice a day for the first two days; then one drop in each eye once a day for 26 days

Timeline

• Start date: 2009-05-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2009-05-07
• Last updated: 2013-11-21

Locations

26 sites across 1 country: United States